Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status – Yahoo Finance

Patients who are anti-JCV antibody positive, have received prior immunosuppressant (IS) therapy and have received treatment with TYSABRI for more than two years have the highest risk of developing PML. “TYSABRI has benefited thousands of …